Results 221 to 230 of about 16,022 (277)

Investigations of the effects of different ventilation structures on physiologically based pharmacokinetic modeling (PBPK) simulations [PDF]

, 2016
Yokley, Karen A
core   +1 more source

Application of Physiologically-Based Pharmacokinetic Modeling to Support Drug Labeling: Prediction of CYP3A4-Mediated Pirtobrutinib-Drug Interactions. [PDF]

CPT Pharmacometrics Syst Pharmacol
Tian DD, Hall SD, Chapman SC, Posada MM.
europepmc   +1 more source

In vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in rats [PDF]

core   +1 more source

Physiologically Based Pharmacokinetic Modeling of Valemetostat to Inform Dose Recommendations When Coadministered With CYP3A/P-gp Modulators. [PDF]

Clin Transl Sci
Watanabe A, Okudaira N, Tachibana M, Kazui M, Kotsuma M, Shimizu T, Lau Y.   +6 more
europepmc   +1 more source

Building Sub-Saharan African PBPK Populations Reveals Critical Data Gaps: A Case Study on Aflatoxin B1. [PDF]

Toxins (Basel)
Lootens O, De Boevre M, De Saeger S, Van Bocxlaer J, Vermeulen A.   +4 more
europepmc   +1 more source

Ai-Driven Modeling of Chloroform Exposure in Pools Using Pbpk-Simulated and Experimental Data: Implications for Environmental Exposure Science

Laurent Simon
openalex   +1 more source

QSAR-based physiologically based pharmacokinetic (PBPK) modeling for 34 fentanyl analogs: model validation, human pharmacokinetic prediction and abuse risk insights. [PDF]

Front Pharmacol
Zhang S, Xu Y, Zeng X, Ran J, Chen Y, Kuai L, Li K, Xu P, Yan F, Wang D.   +9 more
europepmc   +1 more source

Assessment of Telisotuzumab Vedotin Drug-Drug Interaction Potential Using Physiologically-Based Pharmacokinetic Modeling and Simulations. [PDF]

J Clin Pharmacol
Riad MMH, Brunsdon P, Menon R, Marroum P, Parikh A.   +4 more
europepmc   +1 more source

Food Quality Protection Act of 1996: Science and Law at a Crossroads [PDF]

, 1997
Miller, Andrew J.
core   +1 more source

Low-dose methotrexate adverse reaction risk in renal impairment: pharmacovigilance and physiological pharmacokinetic model assessment. [PDF]

Front Pharmacol
Zhang L, Li J, Wang X, Zhang Y, Gao S, Dong D, Zhu Y, Yang S.   +7 more
europepmc   +1 more source